On February 22, Gelonghui Tibetan Medicine (002287.SZ) announced its 2023 annual performance report. During the reporting period, the company achieved total revenue of 2,045 billion yuan, an increase of 0.02% over the same period last year. The company achieved operating profit of 648 million yuan, an increase of 24.34% over the same period last year; realized net profit attributable to shareholders of listed companies of 612 million yuan, an increase of 29.49% over the same period of the previous year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 400 million yuan, a year-on-year decrease of 9.02%; and basic earnings per share of 1.1,549 yuan.
奇正藏药(002287.SZ)业绩快报：2023年度归母净利润6.12亿元 同比增长29.49%
Qizheng Tibetan Medicine (002287.SZ) Performance Report: Net profit of 612 million yuan to the mother in 2023 increased 29.49% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.